Dec 31, 2025 12:55PM
Oct 14, 2025 06:22AM
Oct 14, 2025 06:21AM
Oct 8, 2025 06:33AM
Sep 19, 2025 06:08AM
Jul 17, 2025 06:07AM
Jul 10, 2025 06:02AM Goldman Sachs Reiterates Conviction Buy Rating on Johnson & Johnson (JNJ)
May 14, 2025 04:40PM
Apr 8, 2025 05:07AM
Feb 15, 2025 10:00PM
Jan 22, 2025 11:11AM
Sep 16, 2024 05:03AM
May 30, 2024 07:25AM
May 15, 2024 05:49AM Kenvue (KVUE) Prices 182.33M Share Secondary Offering at $20/sh
May 14, 2024 07:13PM
May 13, 2024 06:53AM
May 13, 2024 06:46AM
May 13, 2024 06:46AM
May 8, 2024 04:30PM
Apr 14, 2024 02:00PM
Oct 12, 2023 09:04AM Higher for longer? No problem. These stocks are less vulnerable to rising rates - Goldman
Aug 23, 2023 06:21AM
Aug 23, 2023 06:20AM
Aug 21, 2023 06:20AM
Aug 16, 2023 06:52PM
Jul 24, 2023 06:26AM
Jul 24, 2023 06:18AM
Jul 19, 2023 08:29AM Goldman Sachs, Johnson&Johnson fall premarket; Carvana, Microsoft rise
Jul 17, 2023 08:49AM
May 10, 2023 04:30PM
May 8, 2023 04:35PM
May 8, 2023 04:33PM
May 4, 2023 05:28AM
May 3, 2023 07:22PM
Apr 24, 2023 05:10PM Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO
Apr 24, 2023 04:27PM
Apr 19, 2023 05:37AM
Apr 17, 2023 08:24AM
Dec 16, 2022 07:11AM
Nov 1, 2022 06:30AM
Nov 1, 2022 06:30AM
Oct 18, 2022 08:02AM Goldman Sachs, Johnson&Johnson, Apple Rise Premarket; Hasbro Falls
Jul 19, 2022 08:59AM
May 12, 2022 04:30PM
Apr 20, 2022 07:44AM
Apr 19, 2022 05:54AM
Jan 26, 2022 07:36AM
Dec 17, 2021 06:44AM
Nov 12, 2021 06:31AM Johnson & Johnson (JNJ) to separate the Company's Consumer Health business
Nov 12, 2021 06:30AM

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All